Genetic dissection of murine susceptibilities to liver and lung tumors based on the two-stage concept of carcinogenesis

Pathology International

Volumn 48, Issue 12, 1998, Pages 925-933

  Lee, Gang Hong ^a  

^a ASAHIKAWA MEDICAL COLLEGE   (Japan)

Author keywords

Genetic susceptibility; Initiation; Liver tumor; Lung tumor; Mouse; Promotion

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CHROMOSOME MAP; CONTROLLED STUDY; GENETIC HETEROGENEITY; GENETIC LINKAGE; GENETIC PREDISPOSITION; INBRED STRAIN; LIVER TUMOR; LUNG TUMOR; MOUSE; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; REVIEW; SEGREGATION ANALYSIS; STRAIN DIFFERENCE;

EID: 0032407372     PISSN: 13205463     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1827.1998.tb03863.x     Document Type: Review

References (60)

1. Berenblum I. The carcinogenic action of croton resin. Cancer Res. 1941; 1: 44-48.
2. Friedewald WF, Rous P. The initiating and promoting elements in tumor production. J. Exp. Med. 1944; 80: 101-126.
3. Berenblum I. Carcinogenesis as a Biological Problem. North Holland Publishing Co., Amsterdam, 1974.
4. Pitot HC, Sirica AE. The stages of initiation and promotion in hepatocarcinogenesis. Biochim. Biophys. Acta 1980; 605: 191-215.
5. Akazaki K, Stemmermann GN. Comparative study of latent carcinoma of the prostate among Japanese in Japan and Hawaii. J. Natl Cancer Inst. 1973; 50: 1137-1144.
6. Drinkwater NR, Lee G-H. Genetic susceptibility to liver cancer. In: Jirtle RL, ed. Liver Regeneration and Carcinogenesis: Molecular and Cellular Mechanisms. Academic Press, San Diego, 1995; 301-321.
7. Malkinson AM, Beer DS. Major effect on susceptibility to urethane induced pulmonary adenoma by a single gene in BALB/cBy mice. J. Natl Cancer Inst. 1983; 70: 931-936.
8. Dietrich W, Katz H, Lincoln SE et al. A genetic map of the mouse suitable for typing intraspecific crosses. Genetics 1992; 131: 423-447.
9. Lander ES, Botstein D. Mapping Mendelian factors underlying quantitative traits using RFLP linkage maps. Genetics 1989; 121: 185-199.
10. Lee G-H, Nomura K, Kitagawa T. Comparative study of diethylnitrosamine-initiated two-stage hepatocarcinogenesis in C3H, C57BL and BALB mice promoted by various hepatopromoters. Carcinogenesis 1989; 10: 2227-2230.
11. Vesselinovitch SD, Mihailovich N. Kinetics of diethylnitrosamine hepatocarcinogenesis in the infant mouse. Cancer Res. 1983; 43: 4253-4259.
12. Moore MR, Drinkwater NR, Miller EC, Miller JA, Pitot HC. Quantitative analysis of the time-dependent development of glucose-6-phosphatase-deficient foci in the livers of mice treated neonatally with diethylnitrosamine. Cancer Res. 1981; 41: 1585-1593.
13. Drinkwater NR, Ginsler JJ. Genetic control of hepatocarcinogenesis in C57BL/6J and C3H/HeJ inbred mice. Carcinogenesis 1986; 7: 1701-1707.
14. Bennett LM, Winkler ML, Drinkwater NR. A gene that determines the high susceptibility of the C3H/HeJ strain of mouse to liver tumor induction is located on chromosome one. Proc. Am. Assoc. Cancer Res. 1993; 34: 144.
15. Gariboldi M, Manenti G, Canzian F et al. Chromosome mapping of murine susceptibility loci to liver carcinogenesis. Cancer Res. 1993; 53: 209-211.
16. Manenti G, Binelli G, Gariboldi M et al. Multiple loci affect genetic predisposition to hepatocarcinogenesis in mice. Genomics 1994; 23: 118-124.
17. Lee G-H, Drinkwater NR. Hepatocarcinogenesis in BXH recombinant inbred strains of mice: Analysis of diverse phenotypic effects of the hepatocarcinogen sensitivity loci. Mol. Carcinog. 1995; 14: 190-197.
18. Hanigan MH, Kemp CJ, Ginsler JJ, Drinkwater NR. Rapid growth of preneoplastic lesions in hepatocarcinogen-sensitive C3H/HeJ male mice relative to C57BL/6J male mice. Carcinogenesis 1988; 9: 885-890.
19. Grasso P, Hardy J. Strain difference in natural incidence and response to carcinogens. In: Butler WH, Newberne PM, eds. Mouse Hepatic Neoplasia. Elsevier Scientific Publishing Co., Amsterdam, 1975; 111-132.
20. Lee G-H, Sawada N, Mochizuki Y, Nomura K, Kitagawa T. Immortal epithelial cells of normal C3H mouse liver in culture: Possible precursor populations for spontaneous hepatocellular carcinoma. Cancer Res. 1989; 49: 403-409.
21. Lee G-H, Sakai R, Nagao M, Kitagawa T. Role of activated c-H-ras oncogene in the induction and progression of immortal liver epithelial cell lines derived from normal C3H mice. Int. J. Cancer 1991; 47: 60-65.
22. Buchmann A, Bauer-Hofmann R, Mahr J, Drinkwater NR, Luz A, Schwarz M. Mutational activation of the c-Ha-ras gene in liver tumors of different rodent strains: Correlation with susceptibility to hepatocarcinogenesis. Proc. Natl Acad. Sci. USA 1991; 88: 911-915.
23. Dragani TA, Manenti G, Colombo BM et al. Incidence of mutations at codon 61 of the Ha-ras gene in liver tumors of mice genetically susceptible and resistant to hepatocarcinogenesis. Oncogene 1991; 6: 333-338.
24. Lee G-H, Nomura K, Kanda H et al. Strain specific sensitivity to diethylnitrosamine-induced carcinogenesis is maintained in hepatocytes of C3H/HeN↔C57BL/6N chimeric mice. Cancer Res. 1991; 51: 3257-3260.
25. Lee G-H, Bennett LM, Carabeo RA, Drinkwater NR. Identification of hepatocarcinogen-resistance genes in DBA/2 mice. Genetics 1995; 139: 387-395.
26. Lee G-H, Drinkwater NR. The Hcr (hepatocarcinogen resistance) loci of DBA/2J mice partially suppress phenotypic expression of the Hcs (hepatocarcinogen sensitivity) loci of C3H/HeJ mice. Carcinogenesis 1995; 16: 1993-1996.
27. Nishimori H, Ogawa K, Tateno H. Frequent deletion in chromosome 4 and duplication of chromosome 15 in liver epithelial cells derived from long-term culture of C3H mouse hepatocytes. Int. J. Cancer 1994; 59: 108-113.
28. 1 mice exhibit parentally-biased loss of heterozygosity at the Lci (Liver cell immortalization) locus on chromosome 4. Oncogene 1995; 11: 2281-2287.
29. Yeh SH, Chen PJ, Chen HL, Lai MY, Wang CC, Chen DS. Frequent genetic alterations at the distal region of chromosome 1p in human hepatocellular carcinomas. Cancer Res. 1994; 54: 4188-4192.
30. 1 hybrids. J. Natl Cancer Inst. 1973; 50: 1195-1213.
31. MTV- and DBA/2Ncr mice. Carcinogenesis 1986; 7: 215-220.
32. Poole TM, Drinkwater NR. Two genes abrogate the inhibition of murine hepatocarcinogenesis by ovarian hormones. Proc. Natl Acad. Sci. USA 1996; 93: 5848-5853.
33. Poole TM, Drinkwater NR. Strain dependent effects of sex hormones on hepatocarcinogenesis in mice. Carcinogenesis 1996; 17: 191-196.
34. Malkinson AM, Nesbitt MN, Skamene E. Susceptibility to urethane-induced pulmonary adenomas between A/J and C57BL/6J mice: Use of AXB and BXA recombinant inbred lines indicating a three-locus genetic model. J. Natl Cancer Inst. 1985; 75: 971-974.
35. Gariboldi M, Manenti G, Canzian F et al. A major susceptibility locus to murine lung carcinogenesis maps on chromosome 6. Nat. Genet. 1993; 3: 132-136.
36. Festing MFW, Yang A, Malkinson AM. At least four genes and sex are associated with susceptibility to urethane-induced pulmonary adenomas in mice. Genet. Res. 1994; 64: 99-106.
37. Devereux TR, Wiseman RW, Kaplan N et al. Assignment of a locus for mouse lung tumor susceptibility to proximal Chromosome 19. Mamm. Genome 1994; 5: 749-755.
38. Manenti G, Falvella FS, Gariboldi M, Dragani TA, Pierotti MA. Different susceptibility to lung tumorigenesis in mice with an identical Kras2 intron 2. Genomics 1995; 29: 438-444.
39. Andervont HB. Pulmonary tumors in mice. V: Further studies on the influence of hereditary upon spontaneous and induced lung tumors. Public Health Rep. 1938; 53: 232-237.
40. Shimkin MB, Stoner GD. Lung tumors in mice: Application to carcinogenesis bioassay. Adv. Cancer Res. 1975; 21: 1-58.
41. Belinsky SA, Devereux TR, Maronpot RR, Stoner GD, Anderson MW. Relationship between the formation of promutagenic adducts and the activation of the K-ras protooncogene in lung tumors from A/J mice treated with nitrosamines. Cancer Res. 1989; 49: 5305-5311.
42. You M, Candrian U, Maronpot RR, Stoner GD, Anderson MW. Activation of the Ki-ras protooncogene in spontaneously occurring and chemically induced lung tumors of the strain A mouse. Proc. Natl Acad. Sci. USA 1989; 86: 3070-3074.
43. Suzuki Y, Orita M, Shiraishi M, Hayashi K, Sekiya T. Detection of ras gene mutations in human lung cancers by single-strand conformation polymorphism analysis of polymerase chain reaction products. Oncogene 1990; 5: 1037-1043.
44. You M, Wang Y, Stoner GD et al. Parental bias of Ki-ras oncogenes detected in lung tumors from mouse hybrids. Proc. Natl Acad. Sci. USA 1992; 89: 5804-5808.
45. Chen B, Johanson L, Wiest JS, Anderson MW, You M. The second intron of the K-ras gene contains regulatory elements associated with mouse lung tumor susceptibility. Proc. Natl Acad. Sci. USA 1994; 91: 1589-1593.
46. Ryan J, Barker PE, Nesbitt MN, Ruddle FH. KRAS2 as a genetic marker for lung tumor susceptibility in inbred mice. J. Natl Cancer Inst. 1987; 79: 1351-1357.
47. Dragani TA, Manenti G, Della Porta G. Quantitative analysis of genetic susceptibility to liver and lung carcinogenesis in mice. Cancer Res. 1991; 51: 6299-6303.
48. Obata M, Nishimori N, Ogawa K, Lee G-H. Identification of the Par2 (Pulmonary adenoma resistance) locus on mouse chromosome 18, a major genetic determinant for lung carcinogen resistance in BALB/cByJ mice. Oncogene 1996; 13: 1599-1604.
49. Devereux TR, Lin L, Kaplan NL et al. A locus for pulmonary adenoma susceptibility in A/J x BALB/c mice maps to distal chromosome 18. Proc. Am. Assoc. Cancer Res. 1997; 38: 354.
50. Atchley WR, Fitch WM. Gene trees and the origins of inbred strains of mice. Science 1991; 254: 554-558.
51. Karasaki H, Obata M, Ogawa K, Lee G-H. Roles of the Pas1 and Par2 genes in determination of the unique, intermediate susceptibility of BALB/cByJ mice to urethane induction of lung carcinogenesis: Differential effects on tumor multiplicity, size and Kras2 mutations. Oncogene 1997; 15: 1833-1840.
52. Manenti G, Gariboldi M, Fiorino A, Zanesi N, Pierotti MA, Dragani TA. Genetic mapping of lung cancer modifier loci specifically affecting tumor initiation and progression. Cancer Res. 1997; 57: 4164-4166.
53. Manenti G, Gariboldi M, Elango R et al. Genetic mapping of a pulmonary adenoma resistance locus (Par1) in mouse. Nat. Genet. 1996; 12: 455-457.
54. Pataer A, Nishimura M, Kamoto T, Ichioka K, Sato M, Hiai H. Genetic resistance to urethane-induced pulmonary adenomas in SMXA recombinant inbred mouse strains. Cancer Res. 1997; 57: 2904-2908.
55. Fijneman RJ, de Vries SS, Jansen RC, Demant P. Complex interactions of new quantitative trait loci, Sluc1, Sluc2, Sluc3, and Sluc4, that influence the susceptibility to lung cancer in the mouse. Nat. Genet. 1996; 14: 465-467.
56. Kinzler KW, Nilbert MC, Su LK et al. Identification of FAP locus genes from chromosome 5q21. Science 1991; 253: 661-665.
57. Nishisho I, Nakamura Y, Miyoshi Y et al. Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. Science 1991; 253: 665-669.
58. Groden J, Thliveris A, Samowitz W et al. Identification and characterization of the familial adenomatous polyposis coli gene. Cell 1991; 66: 589-600.
59. Joslyn G, Carlson M, Thliveris A et al. Identification of deletion mutations and three new genes at the familial polyposis locus. Cell 1991; 66: 601-613.
60. Cormier RT, Hong KH, Halberg RB et al. Secretory phospholipase Pla2g2a confers resistance to intestinal tumorigenesis. Nat. Genet. 1997; 17: 88-91.